ZENTIVA, K.S. -  

Ranking results:

Past rankings:

2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2018-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 3.464.964 234.872 1
2018 0 2.268.000 270.000 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
APPLIED PROCESS COMPANY LIMITED1
ASTRAZENECA1
BAYER1
F HOFFMANNLA ROCHE1
FACHHOCHSCHULE NORDWESTSCHWEIZ1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
JANSSEN PHARMACEUTICA NV1
JOINT STOCK COMPANY FARMAK1
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS1
PHYSIOLUTION1
RUTGERS THE STATE UNIVERSITY OF NEW JERSEY1
SIEC BADAWCZA LUKASIEWICZ INSTYTUT FARMACEUTYCZNY1
SOLVIAS1
SYDDANSK UNIVERSITET1
THE PROVOST FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN HEREINAFTER TRINITY COLLEGE DUBLIN1
UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY OF IRELAND CORK1
UNIVERSITY OF HELSINKI1
UNIWERSYTET MEDYCZNY IM KAROLA MARCINKOWSKIEGO W POZNANIU1

Constancy:

Total number of partners: 18
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 18
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2021-01-01A fully integrated, animal-free, end-to-end modelling approach to oral drug product development InPharmaparticipant3.464.96411
2018-03-01Open Research Biopharmaceutical Internships Support ORBISparticipant2.268.0009